Full Library

Return to list of results

Management of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Book Section
Authors/contributors
Title
Management of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
Abstract
A common and challenging side effect associated with CAR-T cell therapy is immune cell-associated neurotoxicity syndrome (ICANS), which occurs in 20–60% of patients, of whom 12–30% have severe (≥ grade 3) symptoms.
Book Title
The EBMT/EHA CAR-T Cell Handbook
Date
2022
Publisher
Springer International Publishing
Place
Cham
Pages
141-145
ISBN
978-3-030-94353-0
URL
https://doi.org/10.1007/978-3-030-94353-0_27
Accessed
10/28/23, 7:44 AM
Language
en
Library Catalog
Springer Link
Extra
DOI: 10.1007/978-3-030-94353-0_27
Citation
Rees, J. H. (2022). Management of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). In N. Kröger, J. Gribben, C. Chabannon, I. Yakoub-Agha, & H. Einsele (Eds.), The EBMT/EHA CAR-T Cell Handbook (pp. 141–145). Springer International Publishing. https://doi.org/10.1007/978-3-030-94353-0_27
HEME-ONC AND CELLULAR THERAPIES
Link to this record
https://www.transplantid.net/B9C25NKU